MOASC (@moasc_office) 's Twitter Profile
MOASC

@moasc_office

Our mission is to advance and protect the ability of cancer patients to obtain, and oncology physicians to provide, optimal cancer care.

ID: 835884799

linkhttp://www.moasc.org calendar_today20-09-2012 16:15:55

4,4K Tweet

622 Followers

674 Following

Anthony El-Khoueiry (@drelkhoueiry) 's Twitter Profile Photo

Starting our Los Angeles Cholangiocarcinoma Symposium at USC Norris Comprehensive Cancer Center with the Cholangiocarcinoma Foundation. Patients, caregivers, researchers, clinicians, and advocates gathered together! USC Norris Comprehensive Cancer Center Cholangiocarcinoma Foundation Keck School of Medicine of USC

Starting our Los Angeles Cholangiocarcinoma Symposium at USC Norris Comprehensive Cancer Center with the Cholangiocarcinoma Foundation. Patients, caregivers, researchers, clinicians, and advocates gathered together! <a href="/uscnorris/">USC Norris Comprehensive Cancer Center</a> <a href="/curecc/">Cholangiocarcinoma Foundation</a> <a href="/KECKSchool_USC/">Keck School of Medicine of USC</a>
City of Hope | Orange County (@cityofhopeoc) 's Twitter Profile Photo

For the fourth year in a row, City of Hope Orange County has been named one of Orange County Business Journal’s Best Places to Work! 💙 From uplifting one another to our steadfast commitment to transforming cancer care, it’s our people who make our organization extraordinary.

UC San Diego Health Moores Cancer Center (@ucsdcancer) 's Twitter Profile Photo

Congratulations to Alice L. Yu, MD, PhD, on receiving a Lifetime Achievement Award from the Advances in Neuroblastoma Research Association (ANRA) 🏆 🌟 This award recognizes Dr. Yu's groundbreaking work on an anti-GD2 antibody therapy that has transformed the landscape of

Congratulations to Alice L. Yu, MD, PhD, on receiving a Lifetime Achievement Award from the Advances in Neuroblastoma Research Association (ANRA) 🏆 🌟 

This award recognizes Dr. Yu's groundbreaking work on an anti-GD2 antibody therapy that has transformed the landscape of
OncLive.com (@onclive) 's Twitter Profile Photo

FDA Grants Orphan Drug Designation to FF-10832 for Biliary Tract Cancer ASCO #ASCO25 #oncology onclive.com/view/fda-grant…

City of Hope (@cityofhope) 's Twitter Profile Photo

What are the metabolic links between diabetes, obesity and cancer? How can understanding those connections lead to new ways to prevent and treat multiple diseases? Sumanta K. Pal, MD, FASCO and Charles Brenner, PhD explore these topics on On the Edge of Breakthrough! Watch: bit.ly/4lGtHmX

Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

A true legend in the field of hematology/oncology. Dr. Stephen Forman was involved in the seminal studies of BMT for hematologic malignancies & evolved into a pioneer of CAR-T cell therapy. There are literally dozens of faculty at City of Hope & beyond who consider him to be their

Targeted Oncology (@targetedonc) 's Twitter Profile Photo

📢 Big news in breast cancer treatment! The FDA has granted Breakthrough Therapy Designation to T-DXd + pertuzumab for first-line HER2-positive metastatic breast cancer #BreastCancer #HER2Positive #CancerResearch Read more: targetedonc.com/view/t-dxd-bre…

City of Hope (@cityofhope) 's Twitter Profile Photo

In the newest episode of On the Edge of Breakthrough: Voices of Cancer Research, Sumanta K. Pal, MD, FASCO and Dr. Stephen J. Forman discuss decades of progress in bone marrow transplantation, CAR T cell therapy, the human side of innovation and more. Watch: youtu.be/z8WGtTPgQUU

Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

Legend. It's the first word that comes to mind when I think of Stephen J. Forman, MD City of Hope. He made massive contributions to the world of #BMT as the field came into being & continued on to become a pioneer in CAR-T for both liquid & solid tumors. An inspiration to all

City of Hope (@cityofhope) 's Twitter Profile Photo

Why do we gain belly fat in midlife? City of Hope scientists found that certain fat-producing cells ramp up with age — and identified a new cell type and key protein that drive it. These findings could help prevent age-related weight gain and diabetes. bit.ly/46gtjHy

Salvador Jaime-Casas, MD (@salvadorjcmd) 's Twitter Profile Photo

Stellar presentation by keynote speaker Ashish M. Kamat, MD, MBBS on bladder-sparing options in muscle-invasive disease and nuances of intermediate-risk NMIBC. 🔵 Presented at the 2nd Genitourinary Cancer Research Team @CityofHope City of Hope retreat, made possible by incredible team of physicians led by Wesley Yip

Stellar presentation by keynote speaker <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> on bladder-sparing options in muscle-invasive disease and nuances of intermediate-risk NMIBC. 

🔵 Presented at the 2nd <a href="/CityofHope_GU/">Genitourinary Cancer Research Team @CityofHope</a> <a href="/cityofhope/">City of Hope</a> retreat, made possible by incredible team of physicians led by <a href="/WesleyYipMD/">Wesley Yip</a>
Wesley Yip (@wesleyyipmd) 's Twitter Profile Photo

What an amazing keynote presentation from our VP Ashish M. Kamat, MD, MBBS during our @CityofHope Annual GU Research Retreat organized by @MontyPal and Tanya Dorff. A visit full of inspiring discussions for future collaboration over delicious food (can always trust Clayton Lau with the menu)

What an amazing keynote presentation from our VP <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> during our @CityofHope Annual GU Research Retreat organized by @MontyPal and <a href="/TDorffOnc/">Tanya Dorff</a>.  A visit full of inspiring discussions for future collaboration over delicious food (can always trust <a href="/ClaytonLauMD/">Clayton Lau</a> with the menu)
Sia Daneshmand, M.D. (@siadaneshmand) 's Twitter Profile Photo

Just published online in Journal of Clinical Oncology : #SunRISe1 Phase IIb results show TAR-200 (novel intravesical drug releasing system) achieves 82.4% CR in BCG-unresponsive high-risk NMIBC—with durable responses (median DOR 25.8 mo) & low toxicity. A game-changer for pts with #NMIBC.

Ashley Love Sumrall, MD, FACP, FASCO (@ashleysumrallmd) 's Twitter Profile Photo

Our #advocacy matters! As an ASCO member & AMA HOD member, I love seeing this collaborative #advocacy step 👇🏻👇🏻👇🏻 #onctwitter